Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

Clinical trial NCT03206060 · RECRUITING

Trial details

NCT number: NCT03206060
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pheochromocytoma Paraganglioma Neuroendocrine Tumors Neuroendocrine Neoplasms

Start date: 2017-10-10
Primary completion: 2030-01-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.